Hey everyone! If you're exploring new investment opportunities for late October, consider taking a look at NurExone (TSXV: NRX, OTCQB: NRXBF, FRA: J90). The...
NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company developing exosome-based therapies for the multi-billion dollar regenerative medicine market....
Zacks values NurExone at $2.55 per share—a huge upside from $0.54.
ExoPTEN, its breakthrough spinal cord treatment, shows promising results.
FDA Orphan Drug Designation gives it...
Something extraordinary occurred on Tuesday—Bright Minds Biosciences (DRUG) surged by an astonishing 1,000%, with a staggering 3,000% gain over the last five days. Incredible,...